Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Ningbo University is active in the Biotechnology & Pharmaceuticals technology area with 3 pending office actions. These actions are distributed across 3 distinct examiners, indicating that each pending matter is being handled by a different individual. This distribution suggests a variety of perspectives within the examination process, even as the work remains within a single technical field.
All 3 pending office actions are located within 1 distinct art unit. This concentration within a single art unit implies that while the examiners differ, the technical subject matter remains closely related. ALLEN, ANDRE J is identified as the busiest examiner for the portfolio, with 1 pending office action currently assigned. This examiner's workload is representative of the balanced distribution across the portfolio.
The workload is evenly spread, as the busiest examiner is responsible for 1 of the 3 total pending actions. This distribution means that no single examiner dominates the portfolio's prosecution. Practitioners should be prepared to address the specific nuances of three different examiners while operating within the consistent framework of 1 distinct art unit. This structure requires a flexible strategy that accounts for multiple individual examiner preferences.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §101 + other | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALLEN, ANDRE J | 1 | 91.4% | +6.4% |
| GOLDBERG, JEANINE ANNE | 1 | 45.8% | +40.8% |
| SWIFT, CANDICE LEE | 1 | 57.5% | +36.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278425 | Bacterial colony formation method for sensitive and rapid culture of helicobacter pylori and effect evaluation method for same | SWIFT, CANDICE LEE | 42d overdue |
| 18802230 | METHOD FOR EVALUATING COMPREHENSIVE PERFORMANCE OF ACOUSTO-OPTIC CHALCOGENIDE GLASS MATERIAL | ALLEN, ANDRE J | — |
| 18833488 | USE OF HYPOXIA-INDUCIBLE FACTOR 1 ALPHA AS MARKER IN DEPRESSION RECURRENCE DIAGNOSIS | GOLDBERG, JEANINE ANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278425 | Bacterial colony formation method for sensitive and rapid culture of helicobacter pylori and effect evaluation method for same | SWIFT, CANDICE LEE | 42d overdue |
| 18833488 | USE OF HYPOXIA-INDUCIBLE FACTOR 1 ALPHA AS MARKER IN DEPRESSION RECURRENCE DIAGNOSIS | GOLDBERG, JEANINE ANNE | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18802230 | METHOD FOR EVALUATING COMPREHENSIVE PERFORMANCE OF ACOUSTO-OPTIC CHALCOGENIDE GLASS MATERIAL | ALLEN, ANDRE J | — | §101 | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18833488 | USE OF HYPOXIA-INDUCIBLE FACTOR 1 ALPHA AS MARKER IN DEPRESSION RECURRENCE DIAGNOSIS | GOLDBERG, JEANINE ANNE | — | §101§102§112 | Non-Final OA | — | Pending | Jul 26, 2024 |
| 18278425 | Bacterial colony formation method for sensitive and rapid culture of helicobacter pylori and effect evaluation method for same | SWIFT, CANDICE LEE | 1657 | §101§103§112 | Final Rejection | 42d overdue | Pending | Aug 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial